Optimization of molecular approaches to genogroup Neisseria meningitidis carriage isolates and implications for monitoring the impact of new serogroup B vaccines

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Rojas, Eduardo ^a   Hoyos, Johanna ^a   Oldfield, Neil J ^b   Lee, Philip ^a   Flint, Mike ^a,c   Jones, C Hal ^a   Ala'Aldeen, Dlawer A A ^b   Jansen, Kathrin U ^a   Anderson, Annaliesa S ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; BINDING PROTEIN; FACTOR H BINDING PROTEIN; UNCLASSIFIED DRUG; MENINGOCOCCUS VACCINE;

AGGLUTINATION TEST; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CTRA GENE; GENE LOCUS; GENE PROBE; GENETIC VARIABILITY; NEISSERIA MENINGITIDIS; NONHUMAN; OPERON; PORA GENE; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MENINGOCOCCAL INFECTIONS;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84940063630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132140     Document Type: Article

References (56)

1. Yazdankhah SP, Caugant DA (2004) Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 53: 821-832. PMID: 15314188
2. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM (2001) Meningococcal disease. N Engl J Med 344: 1378-1388. PMID: 11333996
3. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. (2011) Bacterial meningitis in the United States, 1998-2007. N Engl J Med 364: 2016-2025. doi: 10.1056/NEJMoa1005384 PMID: 21612470
4. Stephens DS, Greenwood B, Brandtzaeg P (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210. PMID: 17604802
5. Mueller JE, Yaro S, Traore Y, Sangare L, Tarnagda Z, Njanpop-Lafourcade BM, et al. (2006) Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003. J Infect Dis 193: 812-820. PMID: 16479516
6. Kristiansen PA, Diomande F, Ba AK, Sanou I, Ouedraogo AS, Ouedraogo R, et al. (2013) Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 56: 354-363. doi: 10.1093/cid/cis892 PMID: 23087396
7. Gasparini R, Amicizia D, Lai PL, Panatto D (2012) Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences. J Prev Med Hyg 53: 50-55. PMID: 23240160
8. Khatami A, Pollard AJ (2010) The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 9: 285-298. doi: 10.1586/erv.10.3 PMID: 20218857
9. Finne J, Leinonen M, Makela PH (1983) Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2: 355-357. PMID: 6135869
10. Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, et al. (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27 Suppl 2: B3-12. doi: 10.1016/j.vaccine.2009.04.071 PMID: 19481313
11. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, et al. (2004) Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 72: 2088-2100. PMID: 15039331
12. Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, et al. (2009) Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis 200: 379-389. doi: 10.1086/600141 PMID: 19534597
13. Jiang HQ, Hoiseth SK, Harris SL, McNeil LK, Zhu D, Tan C, et al. (2010) Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28: 6086-6093. doi: 10.1016/j.vaccine.2010.06.083 PMID: 20619376
14. Anderson AS, Jansen KU, Eiden J (2011) New frontiers in meningococcal vaccines. Expert Rev Vaccines 10: 617-634. doi: 10.1586/erv.11.50 PMID: 21604983
15. Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al. (2014) Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 384: 2123-2131. doi: 10.1016/S0140-6736(14)60842-4 PMID: 25145775
16. Maiden MC, Ibarz-Pavon AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, et al. (2008) Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 197: 737-743. doi: 10.1086/527401 PMID: 18271745
17. Trotter CL, Maiden MC (2009) Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 8: 851-861. doi: 10.1586/erv.09.48 PMID: 19538112
18. Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, et al. (2015) The discovery and development of a novel vaccine to protect against Neisseria meningitidis serogroup B disease. Hum Vaccin Immunother 11: 5-13. doi: 10.4161/hv.34293 PMID: 25483509
19. Harris SL, Zhu D, Murphy E, McNeil LK, Wang X, Mayer LW, et al. (2011) Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease. Hum Vaccin 7: 68-74. PMID: 21245657
20. Claus H, Maiden MC, Maag R, Frosch M, Vogel U (2002) Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148: 1813-1819. PMID: 12055301
21. Dolan-Livengood JM, Miller YK, Martin LE, Urwin R, Stephens DS (2003) Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis 187: 1616-1628. PMID: 12721942
22. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB (2001) Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39: 1553-1558. PMID: 11283086
23. Diggle MA, Clarke SC (2006) Molecular methods for the detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn 6: 79-87. PMID: 16359269
24. Guiver M, Borrow R, Marsh J, Gray SJ, Kaczmarski EB, Howells D, et al. (2000) Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 28: 173-179. PMID: 10799809
25. Tzanakaki G, Tsolia M, Vlachou V, Theodoridou M, Pangalis A, Foustoukou M, et al. (2003) Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR). FEMS Immunol Med Microbiol 39: 31-36. PMID: 14556993
26. Baethgen LF, Moraes C, Weidlich L, Rios S, Kmetzsch CI, Silva MS, et al. (2003) Direct-test PCR for detection of meningococcal DNA and its serogroup characterization: standardization and adaptation for use in a public health laboratory. J Med Microbiol 52: 793-799. PMID: 12909657
27. Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38: 855-857. PMID: 10655397
28. Jordens JZ, Heckels JE (2005) A novel porA-based real-time PCR for detection of meningococcal carriage. J Med Microbiol 54: 463-466. PMID: 15824424
29. Dolan Thomas J, Hatcher CP, Satterfield DA, Theodore MJ, Bach MC, Linscott KB, et al. (2011) sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS ONE 6: e19361. doi: 10.1371/journal.pone.0019361 PMID: 21573213
30. Read RC (2014) Neisseria meningitidis; clones, carriage, and disease. Clin Microbiol Infect 20: 391-395. doi: 10.1111/1469-0691.12647 PMID: 24766477
31. Whiley DM, Crisante ME, Syrmis MW, Mackay IM, Sloots TP (2003) Detection of Neisseria meningitidis in clinical samples by a duplex real-time PCR targeting the porA and ctrA genes. Mol Diagn 7: 141-145. PMID: 15068383
32. Cavrini F, Liguori G, Andreoli A, Sambri V (2010) Multiple nucleotide substitutions in the Neisseria meningitidis serogroup C ctrA gene cause false-negative detection by real-time PCR. J Clin Microbiol 48: 3016-3018. doi: 10.1128/JCM.00103-10 PMID: 20519469
33. Jaton K, Ninet B, Bille J, Greub G (2010) False-negative PCR result due to gene polymorphism: the example of Neisseria meningitidis. J Clin Microbiol 48: 4590-4591. doi: 10.1128/JCM.01766-10 PMID: 20962143
34. Frosch M, Vogel U (2006) Structure and Genetics of the Meningococcal Capsule. In: Frosch M, and, Maiden MCJ, editors. Handbook of Meningococcal Disease. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA. pp. 145-162.
35. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, et al. (2013) Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 19: 566-573. doi: 10.3201/eid1904.111799 PMID: 23628376
36. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, et al. (2004) Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 42: 320-328. PMID: 14715772
37. Wang X, Theodore MJ, Mair R, Trujillo-Lopez E, du Plessis M, Wolter N, et al. (2012) Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol 50: 702-708. doi: 10.1128/JCM.06087-11 PMID: 22170919
38. Gasparini R, Comanducci M, Amicizia D, Ansaldi F, Canepa P, Orsi A, et al. (2014) Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. J Clin Microbiol 52: 1901-1910. doi: 10.1128/JCM.03584-13 PMID: 24648565
39. Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, et al. (2000) Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38: 2311-2316. PMID: 10834994
40. Bennett DE, Mulhall RM, Cafferkey MT (2004) PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J Clin Microbiol 42: 1764-1765. PMID: 15071043
41. Marri PR, Paniscus M, Weyand NJ, Rendon MA, Calton CM, Hernandez DR, et al. (2010) Genome sequencing reveals widespread virulence gene exchange among human Neisseria species. PLoS ONE 5: e11835. doi: 10.1371/journal.pone.0011835 PMID: 20676376
42. Weinstock G, Sodergren E, Clifton S, Fulton L, Fulton B, et al. (2010) N subflava NJ9703 ACEO00000000.2. Available: http://www.ncbi.nlm.nih.gov/Traces/wgs/?val=ACEO02. Accessed 2015.
43. Hoang LM, Thomas E, Tyler S, Pollard AJ, Stephens G, Gustafson L, et al. (2005) Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. Clin Infect Dis 40: e38-42. PMID: 15714405
44. Zhu H, Wang Q, Wen L, Xu J, Shao Z, Chen M, et al. (2012) Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. J Clin Microbiol 50: 46-51. doi: 10.1128/JCM.00918-11 PMID: 22090406
45. Marsh JW, Shutt KA, Pajon R, Tulenko MM, Liu S, Hollick RA, et al. (2011) Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates. Vaccine 29: 6049-6058. doi: 10.1016/j.vaccine.2011.06.025 PMID: 21704667
46. Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, et al. (2015) Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect.
47. Bennett DE, Cafferkey MT (2006) Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease. J Clin Microbiol 44: 1127-1131. PMID: 16517911
48. Fraisier C, Stor R, Tenebray B, Sanson Y, Nicolas P (2009) Use of a new single multiplex PCR-based assay for direct simultaneous characterization of six Neisseria meningitidis serogroups. J Clin Microbiol 47: 2662-2666. doi: 10.1128/JCM.02415-08 PMID: 19553584
49. Snyder LA, Davies JK, Ryan CS, Saunders NJ (2005) Comparative overview of the genomic and genetic differences between the pathogenic Neisseria strains and species. Plasmid 54: 191-218. PMID: 16024078
50. Hammerschmidt S, Muller A, Sillmann H, Muhlenhoff M, Borrow R, Fox A, et al. (1996) Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20: 1211-1220. PMID: 8809773
51. Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, Claus H, et al. (2007) Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis 195: 1071-1077. PMID: 17330799
52. Beddek AJ, Li MS, Kroll JS, Jordan TW, Martin DR (2009) Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains. Infect Immun 77: 2989-2994. doi: 10.1128/IAI.00181-09 PMID: 19451248
53. Tommassen J, Vermeij P, Struyve M, Benz R, Poolman JT (1990) Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins. Infect Immun 58: 1355-1359. PMID: 2157669
54. van der Ende A, Hopman CT, Dankert J (1999) Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect Immun 67: 2928-2934. PMID: 10338501
55. Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, Sanza LT, et al. (2006) Antigenic shift and increased incidence of meningococcal disease. J Infect Dis 193: 1266-1274. PMID: 16586364
56. Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garces-Sanchez M, et al. (2012) Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12: 597-607. PMID: 22569484